Skip to main content

Medical Technology

Convatec Welcomes Postponement of Local Coverage Determinations on Skin Substitutes Until January 2026

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Convatec, a leading provider of medical products and technologies, has expressed its support for the postponement of Local Coverage Determinations (LCDs) for skin substitutes in the United States until January 2026. This delay, made by the Centers for Medicare & Medicaid Services (CMS), ensures that Medicare patients in the US will continue to have access to InnovaMatrix®, a trusted product for treating diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

Dräger Reports Strong Demand in Q1 2025

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May7, 2025 – Drägerwerk AG & Co. KGaA has shown significant growth in its order intake during the first quarter of 2025, marking a strong start to the year despite a seasonally weaker operating result. With order intake reaching approximately EUR 861 million, the company exceeded its prior-year figures by EUR 50 million. Net sales closely mirrored last year's numbers, while operating results remained narrowly positive, reflecting both challenges and opportunities across global markets.

Dräger Unveils the Alcotest 7000: Revolutionizing Alcohol Detection for Safety and Compliance

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Dräger, a global leader in safety technology, has launched the Alcotest 7000, an advanced alcohol screening device that is set to redefine safety protocols in law enforcement, Department of Transportation (DOT) compliance, and workplace safety initiatives. This innovative new product comes with dual-function capability, designed to meet the evolving needs of both criminal justice and safety-sensitive industries. The Alcotest 7000 is poised to enhance accuracy, streamline operations, and contribute to safer roads and workplaces.

Dräger Secures VHA Contract to Enhance Surgical Lighting and Equipment Boom Efficiency

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Dräger, a global leader in medical and safety technology, has been awarded a significant five-year contract by the U.S. Department of Veterans Affairs (VA) under the Non-Expendable (NX) Equipment Program. This contract focuses on providing cutting-edge surgical lighting systems and equipment boom solutions to VA medical facilities, streamlining procurement and enhancing operational efficiency across the healthcare system.

Mindray FA-N Series: Rapid Diagnosis of Bloodstream Infection with Optimized Workflow

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Mindray, a global leader in medical technologies, has announced the launch of its new-generation FA-N Series, an advanced automatic microbial culture system designed to transform the diagnosis of bloodstream infections. This cutting-edge system offers optimized workflows, faster detection times, and enhanced accuracy, addressing key challenges faced by clinical microbiologists and improving patient outcomes.

Terumo Launches "Terumo Group Statement on Nature" to Strengthen Environmental Sustainability Efforts

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Terumo Corporation, a global leader in medical technology, has unveiled its "Terumo Group Statement on Nature," a comprehensive guideline aimed at enhancing the company's commitment to the conservation and restoration of natural environments. This initiative is a strategic step in Terumo's ongoing efforts to reduce its environmental footprint and promote sustainability within its operations and value chain.

Terumo Blood and Cell Technologies Appoints Patrick Daly as Chief Business Officer to Drive Growth and Innovation

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), a leading medical technology company, has announced the appointment of Patrick Daly as its new Chief Business Officer. Daly, a seasoned veteran with over 30 years of experience in the healthcare industry, will play a crucial role in driving business growth and enhancing Terumo BCT's strategic initiatives.

Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Intuitive (NASDAQ: ISRG), a global leader in robotic-assisted surgery, today announced the U.S. Food and Drug Administration (FDA) has granted clearance for its da Vinci Single Port (SP) surgical system for transanal local excision/resection. This clearance, which builds upon previous FDA approvals for transabdominal colorectal procedures, further enhances the capabilities of the da Vinci SP system, supporting minimally invasive surgery via natural orifice access.

Intuitive Reports Strong Q1 2025 Financial Results and Continued Growth in Robotic Surgery Systems

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Intuitive (Nasdaq: ISRG), a global leader in minimally invasive care and robotic-assisted surgery, has announced its financial results for the first quarter of 2025, showcasing impressive growth and a strong strategic position in the healthcare technology market. The company's financial performance highlights robust growth in surgical procedures, system placements, and revenue, underscoring its leadership in the evolving field of robotic-assisted surgery.

Robotic-Assisted Surgery Enhances Access to Minimally Invasive Care

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 7, 2025 – Intuitive, a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), has published two groundbreaking studies highlighting the critical role of RAS in expanding access to high-quality care. These findings emphasize how robotic-assisted procedures contribute to improving patient outcomes, especially in medical deserts, and ultimately aid the growth of minimally invasive surgery (MIS), benefiting patients globally.